Cyxone AB is a clinical-stage biotechnology company headquartered in Malmö, Sweden. It focuses on developing a new generation of disease-modifying therapies for autoimmune and…
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Cyxone →Already a subscriber? Sign in
Xcout Intel tracks Cyxone continuously — this profile deepens as new filings, funding, people and hiring data arrive.